SKI Market

Indian Indices

Sensex

83,576.24 -604.72
( -0.72%)

Global Indices

Nasdaq

49,277.91 260.82
(0.53%)

Dow Jones

6,942.18 0.25
(0.00%)

Hang Seng

51,918.01 800.75
(1.57%)

Nikkei 225

10,051.56 3.35
(0.03%)

Forex

USD-INR

89.93 -0.23
(-0.25%)

EUR-INR

105.10 -0.46
(-0.44%)

GBP-INR

121.29 -0.65
(-0.53%)

JPY-INR

0.57 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Valiant Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543998

INE0JWS01017

58.4359033

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VALIANTLAB

56.14

384.21

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

KIC Metaliks standalone net profit declines 50.00% in the September 2025 quarter

Nov 16,2025

Net profit of KIC Metaliks declined 50.00% to Rs 0.08 crore in the quarter ended September 2025 as against Rs 0.16 crore during the previous quarter ended September 2024. Sales declined 22.10% to Rs 182.42 crore in the quarter ended September 2025 as against Rs 234.18 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	182.42	234.18	-22
OPM %	3.82	2.72	-
PBDT	3.88	3.84	1
PBT	0.15	0.12	25
NP	0.08	0.16	-50

83,576.24 -604.72 ( -0.72%)

49,277.91 260.82 (0.53%)

6,942.18 0.25 (0.00%)

51,918.01 800.75 (1.57%)

10,051.56 3.35 (0.03%)

89.93 -0.23 (-0.25%)

105.10 -0.46 (-0.44%)

121.29 -0.65 (-0.53%)

0.57 0.00 (-0.31%)